BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26454613)

  • 1. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated whole-breast radiotherapy and concomitant boost after breast conservation in elderly patients.
    Cante D; Franco P; Sciacero P; Girelli G; Pasquino M; Casanova Borca V; Tofani S; Porta MR; Ricardi U
    Tumori; 2016; 102(2):196-202. PubMed ID: 26350199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.
    Kyrgias G; Zygogianni A; Theodorou K; Koukourakis M; Oikonomou A; Kouvaris J; Kouloulias V
    Am J Clin Oncol; 2015 Aug; 38(4):358-63. PubMed ID: 23934132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
    Bantema-Joppe EJ; Schilstra C; de Bock GH; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e471-7. PubMed ID: 22494592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
    Ghannam AA; Khedr RA
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
    Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
    Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.
    Arcadipane F; Franco P; De Colle C; Rondi N; Di Muzio J; Pelle E; Martini S; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ragona R; Ricardi U
    Med Oncol; 2016 Oct; 33(10):108. PubMed ID: 27573380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
    Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
    Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
    Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
    Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
    Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
    Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients.
    Deantonio L; Cozzi S; Tunesi S; Brambilla M; Masini L; Pisani C; Gambaro G; Magnani C; Krengli M
    Tumori; 2016 Aug; 102(4):398-403. PubMed ID: 27230276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.